Junjie Xiao Selected Research

Junjie Xiao Research Topics

Disease

23	Heart Failure 12/2021 - 01/2010
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2012
13	Myocardial Infarction 01/2022 - 08/2012
11	Muscular Atrophy (Muscle Atrophy) 06/2022 - 01/2017
9	Hypertrophy 07/2022 - 07/2010
9	Reperfusion Injury 01/2021 - 04/2010
8	Atrial Fibrillation 01/2014 - 12/2006
7	Fibrosis (Cirrhosis) 01/2021 - 04/2013
7	Ischemia 01/2019 - 01/2010
6	Neoplasms (Cancer) 05/2022 - 01/2017
5	Inflammation (Inflammations) 06/2022 - 01/2016
5	Hypertension (High Blood Pressure) 01/2021 - 01/2017
4	Heart Diseases (Heart Disease) 02/2022 - 03/2010
4	Cardiac Arrhythmias (Arrythmia) 01/2021 - 07/2009
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 07/2009
4	Pathologic Processes 12/2018 - 01/2014
3	Atrophy 01/2021 - 01/2017
3	Atherosclerosis 01/2020 - 01/2017
3	Sepsis (Septicemia) 01/2017 - 01/2016
3	Infarction (Infarctions) 01/2016 - 05/2011
3	Necrosis 06/2015 - 12/2012
2	Cardiomegaly (Heart Hypertrophy) 07/2022 - 10/2018
2	Cachexia 12/2021 - 01/2017
2	Ventricular Remodeling 01/2021 - 01/2017
2	Peripheral Arterial Disease 01/2021 - 01/2021
2	Muscle Cramp (Cramp) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2017 - 01/2017
2	Stroke (Strokes) 01/2017 - 08/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 08/2012
2	Alcoholic Fatty Liver 02/2016 - 01/2016
2	Pulmonary Embolism 08/2012 - 09/2011
1	Marfan Syndrome (Marfan's Syndrome) 10/2022
1	Thrombosis (Thrombus) 01/2022
1	Cardiotoxicity 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Peripheral Nerve Injuries 12/2021
1	Chronic Renal Insufficiency 12/2021
1	Chronic Disease (Chronic Diseases) 12/2021

Drug/Important Bio-Agent (IBA)

28	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2010
14	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
7	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2010
6	Angiotensin IIIBA 07/2022 - 01/2020
5	mouse MIRN29 microRNAIBA 06/2022 - 01/2017
5	Pharmaceutical PreparationsIBA 02/2022 - 01/2010
4	Circular RNAIBA 05/2022 - 01/2018
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 01/2017
3	Insulin (Novolin)FDA Link 01/2022 - 01/2014
3	Biological ProductsIBA 01/2022 - 01/2017
3	Long Noncoding RNAIBA 12/2021 - 01/2021
3	Untranslated RNA (Noncoding RNA)IBA 12/2021 - 12/2015
3	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 01/2017
3	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 01/2014
3	qiliqiangxinIBA 02/2015 - 01/2015
3	Messenger RNA (mRNA)IBA 01/2015 - 01/2014
3	triphenyltetrazoliumIBA 01/2015 - 01/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2011 - 01/2010
3	Cholinergic Agents (Cholinergics)IBA 11/2010 - 04/2010
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2022 - 01/2020
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 01/2021
2	Hormones (Hormone)IBA 12/2021 - 05/2018
2	PPAR gammaIBA 06/2021 - 03/2021
2	CalciumIBA 01/2021 - 01/2010
2	Antimicrobial PeptidesIBA 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	CathelicidinsIBA 01/2020 - 01/2019
2	Estrogens (Estrogen)FDA Link 05/2018 - 07/2009
2	Therapeutic UsesIBA 09/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2016
2	LipopolysaccharidesIBA 10/2016 - 01/2016
2	fibroblast growth factor 21IBA 02/2016 - 01/2016
2	Annexin A5IBA 02/2015 - 12/2012
2	Propidium (Propidium Iodide)IBA 02/2015 - 12/2012
2	Bromodeoxyuridine (BrdU)IBA 04/2014 - 12/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 07/2010 - 04/2010
2	Fura-2 (Fura 2)IBA 07/2010 - 04/2010
1	PhosphoproteinsIBA 10/2022
1	MethyltransferasesIBA 07/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 07/2022
1	Reelin ProteinIBA 01/2022
1	Trans-Activators (Trans-Acting Factor)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	3-hydroxypropionaldehydeIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	LipidsIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	SAR131675IBA 01/2022
1	CCAAT-Enhancer-Binding Protein-betaIBA 01/2022
1	D-Aspartic Acid (D Aspartate)IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	4- (1- (4- hydroxyphenyl)- 2- phenylbuten- 1- yl)phenoxy- n- butyric acidIBA 01/2022

Therapy/Procedure

12	Therapeutics 07/2022 - 01/2015
5	Denervation 06/2022 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Cardiac Resynchronization Therapy 01/2017 - 06/2015
2	Transplantation 04/2014 - 04/2013
1	Immunomodulation 06/2022